SPH Notice - AustralianSuper Pty Ltd
1
Disclosure of beginning to have substantial holding
Section 276, Financial Markets Conduct Act 2013
To New Zealand Stock Exchange
and
To EBOS Group Ltd
Date this disclosure made: 2025-06-02
Date on which substantial holding began: 2025-05-29
Substantial product holder(s) giving disclosure
Full name(s): AustralianSuper Pty Ltd
Summary of substantial holding
Class of quoted voting products: NZEBOE0001S6
Summary for AustralianSuper Pty Ltd
For this disclosure,—
(a) total number held in class: 12,854,170.00
(b) total in class: 203,225,074.00
(c) total percentage held in class: 6.3251
Details of transactions and events giving rise to relevant event Details of the
transactions or other events requiring disclosure: See below
Date of
change
Person whose relevant interest
changed
Nature of
change (6)
Consideration given
in relation to change
(7)
Class and number of
securities affected
Person's
votes
affected
30/01/2025 JPMorgan Nominees Australia Ltd BUY 35.58 ORD 652 652
5/02/2025 JPMorgan Nominees Australia Ltd BUY 37.62 ORD 401 401
13/02/2025 JPMorgan Nominees Australia Ltd BUY 38.00 ORD 250 250
14/02/2025 JPMorgan Nominees Australia Ltd SELL 37.83 ORD -250 -250
25/02/2025 JPMorgan Nominees Australia Ltd SELL 34.01 ORD -836 -836
11/03/2025 JPMorgan Nominees Australia Ltd SELL 33.99 ORD -217 -217
14/03/2025 JPMorgan Nominees Australia Ltd SELL 33.83 ORD -90 -90
19/03/2025 JPMorgan Nominees Australia Ltd BUY 34.02 ORD 12,064 12,064
20/03/2025 JPMorgan Nominees Australia Ltd BUY 33.87 ORD 9 9
20/03/2025 JPMorgan Nominees Australia Ltd BUY 34.01 ORD 174 174
20/03/2025 JPMorgan Nominees Australia Ltd BUY 34.01 ORD 3,137 3,137
20/03/2025 JPMorgan Nominees Australia Ltd BUY 33.87 ORD 163 163
21/03/2025 JPMorgan Nominees Australia Ltd BUY 34.64 ORD 23 23
21/03/2025 JPMorgan Nominees Australia Ltd BUY 34.18 ORD 7,343 7,343
21/03/2025 JPMorgan Nominees Australia Ltd BUY 33.55 ORD 3,901 3,901
21/03/2025 JPMorgan Nominees Australia Ltd BUY 33.55 ORD 88,579 88,579
21/03/2025 JPMorgan Nominees Australia Ltd BUY 34.18 ORD 132,384 132,384
21/03/2025 JPMorgan Nominees Australia Ltd BUY 36.98 ORD 511 511
21/03/2025 JPMorgan Nominees Australia Ltd BUY 37.90 ORD 22 22
24/03/2025 JPMorgan Nominees Australia Ltd BUY 34.03 ORD 96 96
24/03/2025 JPMorgan Nominees Australia Ltd BUY 34.06 ORD 235 235
24/03/2025 JPMorgan Nominees Australia Ltd BUY 34.03 ORD 1,725 1,725
2
24/03/2025 JPMorgan Nominees Australia Ltd BUY 34.06 ORD 4,241 4,241
25/03/2025 JPMorgan Nominees Australia Ltd BUY 34.00 ORD 661 661
25/03/2025 JPMorgan Nominees Australia Ltd BUY 33.95 ORD 111 111
25/03/2025 JPMorgan Nominees Australia Ltd BUY 34.00 ORD 11,919 11,919
25/03/2025 JPMorgan Nominees Australia Ltd BUY 33.95 ORD 1,995 1,995
26/03/2025 JPMorgan Nominees Australia Ltd BUY 34.03 ORD 1,249 1,249
26/03/2025 JPMorgan Nominees Australia Ltd BUY 34.03 ORD 22,512 22,512
27/03/2025 JPMorgan Nominees Australia Ltd BUY 34.12 ORD 874 874
27/03/2025 JPMorgan Nominees Australia Ltd BUY 34.12 ORD 15,766 15,766
31/03/2025 JPMorgan Nominees Australia Ltd BUY 34.28 ORD 383 383
31/03/2025 JPMorgan Nominees Australia Ltd BUY 34.31 ORD 36 36
31/03/2025 JPMorgan Nominees Australia Ltd BUY 34.28 ORD 6,910 6,910
31/03/2025 JPMorgan Nominees Australia Ltd BUY 34.31 ORD 658 658
1/04/2025 JPMorgan Nominees Australia Ltd BUY 34.46 ORD 128 128
1/04/2025 JPMorgan Nominees Australia Ltd BUY 34.46 ORD 2,310 2,310
3/04/2025 JPMorgan Nominees Australia Ltd BUY 34.81 ORD 6 6
3/04/2025 JPMorgan Nominees Australia Ltd BUY 34.81 ORD 104 104
4/04/2025 JPMorgan Nominees Australia Ltd BUY 35.33 ORD 21 21
4/04/2025 JPMorgan Nominees Australia Ltd BUY 35.33 ORD 372 372
7/04/2025 JPMorgan Nominees Australia Ltd BUY 34.88 ORD 1,775 1,775
7/04/2025 JPMorgan Nominees Australia Ltd BUY 35.14 ORD 11,773 11,773
7/04/2025 JPMorgan Nominees Australia Ltd BUY 34.88 ORD 32,003 32,003
7/04/2025 JPMorgan Nominees Australia Ltd BUY 35.14 ORD 212,276 212,276
8/04/2025 JPMorgan Nominees Australia Ltd BUY 34.82 ORD 48 48
8/04/2025 JPMorgan Nominees Australia Ltd BUY 35.05 ORD 15,000 15,000
8/04/2025 JPMorgan Nominees Australia Ltd BUY 35.05 ORD 270,455 270,455
11/04/2025 JPMorgan Nominees Australia Ltd BUY 36.65 ORD 1,021 1,021
17/04/2025 JPMorgan Nominees Australia Ltd BUY 34.56 ORD 330 330
22/04/2025 JPMorgan Nominees Australia Ltd BUY 34.18 ORD 300 300
23/04/2025 JPMorgan Nominees Australia Ltd BUY 34.30 ORD 300 300
23/04/2025 JPMorgan Nominees Australia Ltd SELL 34.44 ORD -330 -330
24/04/2025 JPMorgan Nominees Australia Ltd BUY 34.36 ORD 300 300
28/04/2025 JPMorgan Nominees Australia Ltd SELL 34.16 ORD -902 -902
1/05/2025 JPMorgan Nominees Australia Ltd BUY 34.36 ORD 1,000 1,000
9/05/2025 JPMorgan Nominees Australia Ltd SELL 35.19 ORD -1,295 -1,295
27/05/2025 JPMorgan Nominees Australia Ltd BUY 35.74 ORD 290 290
29/05/2025 JPMorgan Nominees Australia Ltd BUY 34.51 ORD 400 400
29/05/2025 JPMorgan Nominees Australia Ltd BUY 32.95 ORD 91,006 91,006
29/05/2025 JPMorgan Nominees Australia Ltd BUY 32.95 ORD 4,444,205 4,444,205
Details of relevant interests
Details for AustralianSuper Pty Ltd
Nature of relevant interest(s): eg, registered holder and beneficial owner of financial
products, conditional put option with X Limited, derivative relevant interest over
quoted underlying. State whether a relevant agreement document is attached (with
the number of pages) or need not be attached under regulation 139.
For that relevant interest,—
(a) number held in class: 12,854,170.00
3
(b) percentage held in class: 6.3251
(c) current registered holder(s): Unknown
(d) registered holder(s) once transfers are registered: Unknown
For a derivative relevant interest, also—
(a) type of derivative:
(b) details of derivative: specify details required by the instructions to this form
(c) parties to the derivative:
(d) if the substantial product holder is not a party to the derivative, the nature of the
relevant interest in the derivative:
Details of transactions and events giving rise to substantial holding
An increase of 4,535,611.00 shares on 2025-05-29 caused us to exceed the 5%
threshold on an aggregate basis.
Additional information
Address(es) of substantial product holder(s): Level 30, 130 Lonsdale Street, Melbourne,
3000, VIC, Australia
Contact details: Amar Rashid +61280880813
portfoliocompliance@australiansuper.com
Name of any other person believed to have given, or believed to be required to give, a
disclosure under the Financial Markets Conduct Act 2013 in relation to the financial
products to which this disclosure relates: N/A
Certification
I, Amar Rashid, certify that, to the best of my knowledge and belief, the information
contained in this disclosure is correct and that I am duly authorised to make this disclosure
by all persons for whom it is made.
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- FPH — Fisher & Paykel Healthcare Corporation Limited: SPH Notice - Australian Super Pty Ltd2025-07-29
“1 Disclosure of movement of 1% or more in substantial holding or change in nature of relevant interest, or both Sections 277 and 278, Financial Markets Conduct Act 2013 To XASX and To Fisher & Paykel Healthcare Corporation Ltd Relevant event being disclosed: Movement of 1…”
- ERD — EROAD: SPH Notice - Morgan Stanley2025-04-21
“1 Disclosure of beginning to have substantial holding Section 276, Financial Markets Conduct Act 20 13 To NZX Limited and To EROAD LTD (ERD) Date this disclosure made: 21 April 2025 Date on which substantial holding began: 16 April 2025 Substantial p…”
- ERD — EROAD: SPH Notice - Morgan Stanley2025-04-16
“1 Disclosure of beginning to have substantial holding Section 276, Financial Markets Conduct Act 2013 To NZX Limited and To EROAD LTD (ERD) Date this disclosure made: 16 April 2025 Date on which substantial holding began: 11 April 2025 Substantial product…”